Miika Martikainen
Forskare vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Magnus Essand
- E-post:
- miika.martikainen@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
Publikationer
Senaste publikationer
-
VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
Ingår i Nature Communications, 2024
- DOI för VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
- Ladda ner fulltext (pdf) av VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
-
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Ingår i Cancer Cell, s. 1134-1151, 2023
- DOI för Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
- Ladda ner fulltext (pdf) av Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
-
Ingår i MOLECULAR THERAPY-ONCOLYTICS, s. 37-46, 2021
- DOI för IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
- Ladda ner fulltext (pdf) av IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
-
Ingår i Cell Death and Disease, 2020
- DOI för Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
- Ladda ner fulltext (pdf) av Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
-
Virus-Based Immunotherapy of Glioblastoma
Ingår i Cancers, 2019
- DOI för Virus-Based Immunotherapy of Glioblastoma
- Ladda ner fulltext (pdf) av Virus-Based Immunotherapy of Glioblastoma
Alla publikationer
Artiklar i tidskrift
-
VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
Ingår i Nature Communications, 2024
- DOI för VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
- Ladda ner fulltext (pdf) av VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
-
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Ingår i Cancer Cell, s. 1134-1151, 2023
- DOI för Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
- Ladda ner fulltext (pdf) av Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
-
Ingår i MOLECULAR THERAPY-ONCOLYTICS, s. 37-46, 2021
- DOI för IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
- Ladda ner fulltext (pdf) av IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
-
Ingår i Cell Death and Disease, 2020
- DOI för Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
- Ladda ner fulltext (pdf) av Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
-
Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins
Ingår i Viruses, 2017
- DOI för Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins
- Ladda ner fulltext (pdf) av Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins
-
Ingår i MOLECULAR THERAPY-ONCOLYTICS, s. 67-75, 2017
- DOI för Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity
- Ladda ner fulltext (pdf) av Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity
-
Ingår i Translational Oncology, s. 772-779, 2017
-
Ingår i British Journal of Cancer, s. 51-55, 2017